Epigenetic regulation of prostate cancer

Ruixin Wang, Xiaoqi Liu

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

Prostate cancer is (PCa) the second leading cause of cancer death in males in the United State, with 174,650 new cases and 31,620 deaths estimated in 2019. It has been documented that epigenetic deregulation such as histone modification and DNA methylation contributes to PCa initiation and progression. EZH2 (enhancer of zeste homolog 2), the catalytic subunit of the Polycomb Repressive Complex (PRC2) responsible for H3K27me3 and gene repression, has been identified as a promising target in PCa. In addition, overexpression of other epigenetic regulators such as DNA methyltransferases (DNMT) is also observed in PCa. These epigenetic regulators undergo extensive post-translational modifications, in particular, phosphorylation. AKT, CDKs, PLK1, PKA, ATR and DNA-PK are the established kinases responsible for phosphorylation of various epigenetic regulators.

Original languageEnglish
Pages (from-to)606-613
Number of pages8
JournalGenes and Diseases
Volume7
Issue number4
DOIs
StatePublished - Dec 2020

Bibliographical note

Funding Information:
NIH R01 CA157429 (X. Liu), R01 CA192894 (X. Liu), R01 CA196835 (X. Liu), R01 CA196634 (X. Liu). The work was also partially supported by University of Kentucky Cancer Center (P30 CA177558).

Funding Information:
NIH R01 CA157429 (X. Liu), R01 CA192894 (X. Liu), R01 CA196835 (X. Liu), R01 CA196634 (X. Liu). The work was also partially supported by University of Kentucky Cancer Center ( P30 CA177558 ).

Publisher Copyright:
© 2019 Chongqing Medical University

Keywords

  • DNMT
  • EZH2
  • Epigenetics
  • HDAC
  • Phosphorylation
  • Prostate cancer

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics(clinical)
  • Cell Biology

Fingerprint

Dive into the research topics of 'Epigenetic regulation of prostate cancer'. Together they form a unique fingerprint.

Cite this